Metabolic syndrome is a path to cancer
Obesity is the leading component of metabolic syndrome, together with other components and conditions associated with metabolic syndrome it increases the risk of various socially significant non-communicable diseases, including oncopathology of various localizations. The review article presents general data on the relationship between metabolic syndrome and oncogenesis, discusses such common mechanisms of pathogenesis as imbalance of the insulin-insulin-like growth factor-1 system, insulin resistance, hyperinsulinemia, dysfunction of adipocytes and their adipokine regulation, and impaired metabolism of sex hormones.
Authors
- Lyudmila A. Sharonova (ORCID: https://orcid.org/0000-0001-8827-4919)
- E. V. Treneva (ORCID: https://orcid.org/0000-0003-0097-7252)
- О В Косарева (ORCID: https://orcid.org/0009-0006-4531-9682)
- Yu. A. Dolgikh (ORCID: https://orcid.org/0000-0001-6678-6411)
- P. Ya. Merzlova (ORCID: https://orcid.org/0009-0004-6243-6528)
- Dmitrii P. Kurmaev (ORCID: https://orcid.org/0000-0003-4114-5233)
- Шаронова Анастасия Антоновна (ORCID: https://orcid.org/0009-0009-5916-5129)
Institutions
- Samara State Medical University (RU)
Publication Details
- Journal
- Экспериментальная и клиническая гастроэнтерология
- Published
- 2026-11-18
- DOI
- https://doi.org/10.31146/1682-8658-ecg-248-4-5-14
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00